Thursday, November 26, 2020

Trade bodies assure support to community pharmacists in case of no-deal Brexit

The Company Chemists’ Association (CCA), Association of Independent Multiple Pharmacies (AIM), National Pharmacy Association (NPA), Pharmaceutical Services Negotiating Committee (PSNC) and Royal Pharmaceutical Society...

Public satisfaction with NHS hits lowest in a decade

Britons' satisfaction with the National Health Service (NHS) hits an all-time low in over a decade despite a £20 billion funding boost from the Prime Minister,...

GPhC to go ahead with fee increase despite strong opposition

Majority of the pharmacists expressed strong disagreement over the General Pharmaceutical Council’s (GPhC) proposed pharmacist entry and renewal fees increase. According to the GPhC council...

Fraudulent prescriptions reported in South Manchester

The National Pharmacy Association on Tuesday issued a warning regarding fraudulent prescriptions presented in South Manchester area pharmacies. Fraudulent FP10 prescriptions have been presented in...

PHE launches first national campaign for cervical screening

Public Health England today launched its first national cervical screening campaign to highlight the importance of attending cervical cancer screenings regularly. The national ‘Cervical Screening...

Napp launches biosimilar of chemotherapy drug pegfilgrastim in the UK

Napp Pharmaceuticals has launched Pelmeg, a biosimilar of pegfilgrastim, in the UK, following the European Commission (EC) approval in November. Pelmeg is indicated for the...

OxyContin maker Purdue Pharma exploring bankruptcy

OxyContin maker Purdue Pharma LP is exploring filing for bankruptcy to address potentially significant liabilities from roughly 2,000 lawsuits alleging the drugmaker contributed to the deadly...
Feraccru

Oral iron deficiency drug Feraccru shows comparable efficacy to IV drug in clinical trial

The results from AEGIS Head-to-Head (H2H) clinical trial, which compared Feraccru (ferric maltol) and Ferinject (ferric carboxymaltose (FCM)), is positive, Shield Therapeutics and Norgine announced...

Pharma industry expects ‘leading role’ in rare diseases strategy

The Department of Health and Social Care on Wednesday published a 2019 update to the UK strategy for rare diseases implementation plan, which describes the...

NHS Assembly gets co-chairs; Members to be appointed soon to Long Term Plan advisory...

Former RCGP chair Dr Clare Gerada and King Fund’s former chief executive Professor Sir Chris Ham have been appointed as the co-chairs of a...